Financhill
Back

Liquidia Vs. Arcturus Therapeutics Holdings Industry Stock Comparison

Buy
57

LQDA
Liquidia

Last Price:
10.65
Seasonality Move:
42.57%
Sell
24

ARCT
Arcturus Therapeutics Holdings

Last Price:
16.94
Seasonality Move:
13.46%
Buy
57
Liquidia (LQDA) is a Buy

Is Liquidia a Buy, Sell or Hold?

  • The current Liquidia [LQDA] share price is $10.65. The Score for LQDA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • LQDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?

  • The current Arcturus Therapeutics Holdings [ARCT] share price is $16.91. The Score for ARCT is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LQDA Stock Price Chart

What is Liquidia's stock price today?

  • The Liquidia share price today is $10.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LQDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

ARCT Stock Price Chart

What is Arcturus Therapeutics Holdings's stock price today?

  • The Arcturus Therapeutics Holdings share price today is $16.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight buying pressure.

LQDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 52.84 Buy
Chaikin Money Flow: 812424 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.23 - 11.07) Sell
Bollinger Bands (100): (9.73 - 11.91) Sell

ARCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.92 Sell
Relative Strength Index (14 RSI): 41.59 Sell
Chaikin Money Flow: 48297 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.22 - 19.76) Sell
Bollinger Bands (100): (18.68 - 22.92) Sell

LQDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.13 Buy
20-day SMA: 10.54 Buy
50-day SMA: 10.55 Buy
200-day SMA: 12.29 Sell
8-day EMA: 10.29 Buy
20-day EMA: 10.45 Buy
50-day EMA: 10.6 Buy
200-day EMA: 11.07 Sell

ARCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.25 Sell
20-day SMA: 18.18 Sell
50-day SMA: 20.23 Sell
200-day SMA: 26.65 Sell
8-day EMA: 17.32 Sell
20-day EMA: 18.22 Sell
50-day EMA: 19.63 Sell
200-day EMA: 23.98 Sell

Liquidia Earnings Growth & LQDA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.62 per share, and an increase next year of $0.37 per share.

Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.71 per share.

Liquidia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arcturus Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):